DOT’s Office of Drug and Alcohol Policy and Compliance (ODAPC) Issues Guidance on COVID-19 Impact on Drug Testing
The Department of Transportation’s Office of Drug and Alcohol Policy and Compliance (ODAPC) issued guidance on March 23, 2020
Q: What happens if my agency is unable to conduct DOT drug or alcohol testing due to COVID-19 supply shortages and facility closures?
A: If you are unable to conduct DOT drug or alcohol training or testing due to COVID-19-related supply shortages, facility closures, State or locally imposed quarantine requirements, or other obstacles, you are to continue to comply with existing applicable DOT Agency requirements to document why a test was not completed. If training or testing can be conducted later, you are to do so in accordance with applicable modal regulations.
Information on the Department-wide Guidance and coronavirus response can be found at www.transportation.gov/coronavirus.
Please visit the ODAPC website for additional questions and answers.
Tim Thoelecke, CSAPA, is the founder of InOut Labs.
InOut Labs is a nationwide provider of employee drug testing services, and your best choice for affordable, direct-to-consumer health tests. Tim Thoelecke is a Certified Substance Abuse Program Administrator, Breath Alcohol Technician Trainer and a Certified Professional Collector Trainer, certified in drug and alcohol testing for DOT and non-DOT employers. He is a graduate of Duke University, the Keller Graduate School of Business, the Goldman Sachs 10,000 Small Businesses program, and he founded InOut Labs to help employers and individuals take control of their health, culture and safety. InOut Labs also provides corporate wellness screenings, flu shot clinics, DNA testing and direct-to-consumer lab tests and B12 shots.
Tim is an enthusiastic networker and enjoys connecting people.
InOut Labs is BBB Accredited with an A+ Rating.